Clinical Outcomes of Intravenous Ketamine Treatment for Depression in the VA Health System
2024 · The Journal of Clinical Psychiatry · 6 citations
https://doi.org/10.4088/jcp.23m14984
J
Jamarie Geller
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
53
Citations
4
h-index
1
i10-index
Jamarie Geller is an academic researcher from University of Michigan–Ann Arbor. The author has contributed to research in topics: Treatment of Major Depression & Tryptophan and brain disorders & Psychedelics and Drug Studies. The author has an h-index of 4, co-authored 13 publications.
ORCID: 0000-0001-9049-4400Papers by this author
worksVital Sign Changes During Intravenous Ketamine Infusions for Depression: An Exploratory Study of Prognostic Indications.
2022 · PubMed · 3 citations
https://doi.org/10.1097/jcp.0000000000001542
Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma
2024 · Current Psychiatry Reports · 2 citations
https://doi.org/10.1007/s11920-024-01577-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat